Table 1 Characteristics of patients with HSCC

From: NVP-BEZ235, a dual PI3K-mTOR inhibitor, suppresses the growth of FaDu hypopharyngeal squamous cell carcinoma and has a synergistic effect with Cisplatin

Characteristic

No. of patients

Sex

  Male

12

  Female

0

Median age, y (range)

50.0 (41–68)

Staging

  I

0

  II

4

  III

0

  IV

8

T stage

  T0

1

  T1

0

  T2

5

  T3

2

  T4a

4

  T4b

0

N stage

  N0

5

  N1

2

  N2a

0

  N2b

4

  N2c

1

Two-year survival

  Expired

6

  Survived

6

Back to article page